您的位置: 首页 > 农业专利 > 详情页

RNAi agents for inhibiting expression of alpha-ENaC and methods of use
专利权人:
Arrowhead Pharmaceuticals; Inc.
发明人:
LI, Zhen,ZHU, Rui,PEI, Tao,NICHOLAS, Anthony,BUSH, Erik W.
申请号:
AU2018297262
公开号:
AU2018297262A1
申请日:
2018.07.05
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
Described are RNAi agents, compositions that include RNAi agents, and methods for inhibition of an alpha-ENaC (SCNN1A) gene. The alpha-ENaC RNAi agents and RNAi agent conjugates disclosed herein inhibit the expression of an alpha-ENaC gene. Pharmaceutical compositions that include one or more alpha-ENaC RNAi agents, optionally with one or more additional therapeutics, are also described. Delivery of the described alpha-ENaC RNAi agents to epithelial cells, such as pulmonary epithelial cells,
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充